Cancer survivors who received treatment at the University of Michigan Health Rogel Cancer Center and infusion nurses demystify the experience by providing 10 helpful things to know ahead of time.

Michigan Medicine research tracks academic trajectories of late preterm infants from infancy to kindergarten and identifies developmental risks and how to best promote resilience

Early findings of two studies from the University of Michigan Rogel Cancer Center shed light on new ways to anticipate recurrence in HPV-positive head and neck cancer sooner. The papers, published in Cancer and Oral Oncology, offer clinical and technological perspectives on how to measure if recurrence is happening earlier than current blood tests allow, and provide a framework for a new, more sensitive blood test that could help in this monitoring.

A free online tool could potentially save some prostate cancer patients more than $9,000 in out-of-pocket drug costs, a Michigan Medicine study finds.

Research from the University of Michigan Department of Neurosurgery and Rogel Cancer Center shows promising early results that a therapy combining cell-killing and immune-stimulating drugs are safe and effective in extending survival for patients with gliomas, a highly aggressive form of brain cancer.

As researchers explored potential reasons behind racial disparities in treatment outcomes for children with severe sleep apnea, they were expecting to find the answer in socioeconomic factors. But they were surprised to learn that when one risk factor – obesity – was taken out of the equation, race was no longer associated with worse post-surgery outcomes for obstructive sleep apnea.

Overall, emotional health and technology use dominated this year’s top 10 list of parent concerns about health-related issues for kids in the U.S.– surpassing childhood obesity, which parents rated the number one children’s health issue a decade ago.

A potential drug candidate called ONC201 nearly doubled survival for patients with diffuse midline glioma and DIPG.

Baby diagnosed with duodenal stenosis is doing great after complex surgery at C.S. Mott Children's Hospital in Ann Arbor

A study from the University of Michigan Rogel Cancer Center uncovers a new mechanism to explain why some prostate tumors switch from a common, treatable form to a more rare and aggressive form of prostate cancer.

A study from clinicians and researchers at the University of Michigan Rogel Cancer Center reveals findings from over 800 clinical assays performed for kidney patients with MiTF family gene mutations.

Research from experts at Michigan Medicine, the Children’s Hospital of Philadelphia and Penn Medicine is breaking ground on new ways of treating blood disorders, such as sickle cell anemia, through gene therapy.

Doctors try to improve one four-year-old’s life and other patients like her

Rapid state law changes mean 1 in 4 youth now live more than 4 hours from the closest clinic that could provide medications and hormones, and 1 in 4 clinics must stop offering this service.

A pediatric cancer patient received new 3D metallic ribs from Spain to help treat and manage her disease.